Catching target receptors for drug and vaccine delivery using TOGA® gene expression profiling

Advanced Drug Delivery Reviews

Volumn 54, Issue 9, 2002, Pages 1213-1223

  Lo, David ^a   Hilbush, Brian ^a   Mah, Steven ^a   Brayden, David ^b   Byrne, Daragh ^b   Higgins, Lisa ^b   O'Mahony, Daniel J ^b  

^a Digital Gene Technologies Inc   (United States)

^b ELAN PHARMACEUTICALS   (United States)

Author keywords

M Cell; mRNA; Peyer's patch; Vaccine

Indexed keywords

CELLS; DRUG THERAPY; METABOLISM; VACCINES;

GENE EXPRESSION;

CONTROLLED DRUG DELIVERY;

COMPLEMENTARY DNA; LYMPHOTOXIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TUMOR NECROSIS FACTOR; VACCINE; CARRIER PROTEIN; DRUG;

DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; IN SITU HYBRIDIZATION; INTESTINE EPITHELIUM; MOLECULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEYER PATCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS; ANIMAL; ARTICLE; CYTOLOGY; EPITHELIUM; GENETICS; METABOLISM; METHODOLOGY; MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; EPITHELIUM; GENE EXPRESSION PROFILING; IN SITU HYBRIDIZATION; MICE; PEYER'S PATCHES; PHARMACEUTICAL PREPARATIONS; VACCINES;

EID: 0037027410     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00091-1     Document Type: Article

References (29)

1. Sutcliffe J.G., Foye P.E., Erlander M.G., Hilbush B.S., Bodzin L.J., Durham J.T., Hasel K.W. TOGA: An automated parsing technology for analyzing expression of nearly all genes. Proc. Natl. Acad. Sci. USA. 97:2000;1976-1981.
2. Neutra M.R. The gastrointestinal tract. Weiss L., Cell and Tissue Biology. 6th Edition: 1988;641-683 Urban and Schwarzenberg, Baltimore, MD.
3. Neutra M.R., Pringault E., Kraehenbuhl J.-P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu. Rev. Immunol. 14:1996;275-300.
4. Meynell H.M., Thomas N.W., James P.S., Holland J., Taussig M.J., Nicoletti C. Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. FASEB J. 13:1999;611-619.
5. Borghesi C., Taussig M.J., Nociletti C. Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer's patch. Lab. Invest. 79:1999;1393-1401.
6. Gebert A., Rothkotter H.J., Pabst R. M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167:1996;91-159.
7. Niedergang F., Kraehenbuhl J.-P. Much ado about M cells. Trends Cell Biol. 10:2000;137-141.
8. Bhalla D.K., Owen R.L. Migration of B and T lymphocytes to M cells in Peyer's patch follicle epithelium: an autoradiographic and immunocytochemical study in mice. Cell. Immunol. 81:1983;105-117.
9. Jarry A., Robaszkiewicz M., Brousse N., Potet F. Immune cells associated with M cells in the follicle-associated epithelium of Peyer's patches in the rat. An electron- and immuno-electron-microscopic study. Cell Tissue Res. 255:1989;293-298.
10. Ermak T.H., Owen R.L. Differential distribution of lymphocytes and accessory cells in mouse Peyer's patches. Anat. Rec. 215:1986;144-152.
11. Mayrhofer G., Pugh C.W., Barclay A.N. The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine. Eur. J. Immunol. 13:1983;112-122.
12. Chen Y., Inobe J., Kuchroo V.K., Baron J.L., Janeway Jr C.A., Weiner H.L. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA. 93:1996;388-391.
13. Meyer A.L., Benson J., Song F., Javed N., Gienapp I.E., Goverman J., Brabb T.A., Hood L., Whitacre C.C. Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein. J. Immunol. 166:2001;5773-5781.
14. Garside P., Mowat A.M. Oral tolerance. Semin. Immunol. 13:2001;177-185.
15. Kerneis S., Bogdanova A., Kraehenbuhl J.-P., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 277:1997;949-952.
16. Kerneis S., Caliot E., Stubbe H., Bogdanova A., Kraehenbuhl J.-P., Pringault E. Molecular studies of the intestinal mucosal barrier physiopathology using cocultures of epithelial and immune cells: a technical update. Microbes Infect. 2:2000;1119-1124.
17. Gullberg E., Leonard M., Karlsson J., Hopkins A.M., Brayden D., Baird A.W., Artursson P. Expression of M-cell markers and transport of micro-particles in a new, simplified co-culture of human intestinal epithelial and immune cells. Biochem. Biophys. Res. Commun. 279:2000;808-813.
18. Debard N., Sierro F., Kraehenbuhl J.P. Development of Peyer's patches, follicle-associated epithelium and M cell: lessons from immunodeficient and knockout mice. Semin. Immunol. 11:1999;183-191.
19. Alimzhanov M.B., Kuprash D.V., Kosco-Vilbois M.H., Luz A., Turetskaya R.L., Tarakhovsky A., Rajewsky K., Nedospasov S.A., Pfeffer K. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;9302-9307.
20. Pasparakis M., Alexopoulou L., Grell M., Pfizenmaier K., Bluethmann H., Kollias G. Peyer' patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA. 94:1997;6319-6323.
21. Clark M.A., Jepson M.A., Simmons N.L., Booth T.A., Hirst B.H. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J. Histochem. Cytochem. 41:1993;1679-1687.
22. Sharma R., van Damme E.J., Peumans W.J., Sarsfield P., Schumacher U. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem. Cell Biol. 105:1996;459-465.
23. Clark M.A., Hirst B.H., Jepson M.A. M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 66:1998;1237-1243.
24. Ermak T.H., Giannasca P.J. Microparticle targeting to M cells. Adv. Drug Deliv. Rev. 34:1998;261-283.
25. Yeh P.-Y., Ellens H., Smith P.L. Physiological consideration in the design of particulate dosage forms for oral vaccine delivery. Adv. Drug Deliv. Rev. 34:1998;123-133.
26. Wu Y., Wang X., Csencsits K.L., Haddad A., Walters N., Pascual D.W. M cell-targeted DNA vaccination. Proc. Natl. Acad. Sci. USA. 98:2001;9318-9323.
27. Lo D., Hilbush B., Sutcliffe J.G. Commentary: analysis of gene expression to accelerate target development. Eur. J. Pharm. Sci. 14:2001;191-196.
28. Gebert A., Posselt W. Glycoconjugate expression defines the origin and differentiation pathway of intestinal M-cells. J. Histochem. Cytochem. 45:1997;1341-1350.
29. Gebert A., Fassbinder S., Werner K., Weissferdt A. The development of M cells in Peyer's patches is restricted to specialized dome-associated crypts. Am. J. Pathol. 154:1999;1573-1582.